Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study.

Riepe MW, Walther B, Vonend C, Beer AJ.

BMC Psychiatry. 2015 Jul 11;15:157. doi: 10.1186/s12888-015-0531-9.

2.

Clinical preference for factors in treatment of geriatric depression.

Riepe MW.

Neuropsychiatr Dis Treat. 2014 Dec 22;11:25-31. doi: 10.2147/NDT.S75450. eCollection 2015.

3.

Repetitive pupil light reflex: potential marker in Alzheimer's disease?

Bittner DM, Wieseler I, Wilhelm H, Riepe MW, Müller NG.

J Alzheimers Dis. 2014;42(4):1469-77. doi: 10.3233/JAD-140969.

PMID:
25024346
4.

Autonomous spatial orientation in patients with mild to moderate Alzheimer's disease by using mobile assistive devices: a pilot study.

Lanza C, Knörzer O, Weber M, Riepe MW.

J Alzheimers Dis. 2014;42(3):879-84. doi: 10.3233/JAD-140063.

PMID:
24958461
5.

High-dose cholinergic therapy with rivastigmine patch does not prolong QTc time in patients with Alzheimer's disease.

Riepe MW.

J Clin Psychiatry. 2014 Mar;75(3):288. doi: 10.4088/JCP.13l08730. No abstract available.

PMID:
24717382
6.

[Dementia in Germany: results of an interdisciplinary expert workshop].

Blödt S, Kuhlmey A, Bartholomeyczik S, Behl C, Betsch F, Brinkhaus B, Frühwald M, Füsgen I, Jansen S, Köppel C, Krüger E, Macher M, Michalsen A, Rapp MA, Riepe MW, Schimpf D, Teut M, Warme B, Warning A, Wilkens J, Witt CM.

Wien Med Wochenschr. 2013 Dec;163(23-24):536-40. doi: 10.1007/s10354-013-0252-y. Epub 2013 Nov 22. German.

PMID:
24264454
7.

Efficacy of short-term inpatient rehabilitation for dementia patients and caregivers: prospective cohort study.

Schiffczyk C, Romero B, Jonas C, Lahmeyer C, Müller F, Riepe MW.

Dement Geriatr Cogn Disord. 2013;35(5-6):300-12. doi: 10.1159/000348357. Epub 2013 Apr 5.

PMID:
23572117
8.

Appraising the need for care in Alzheimer's disease.

Schiffczyk C, Romero B, Jonas C, Lahmeyer C, Müller F, Riepe MW.

BMC Psychiatry. 2013 Mar 4;13:73. doi: 10.1186/1471-244X-13-73.

9.

Bupropion and Citalopram in the APP23 Mouse Model of Alzheimer's Disease: A Study in a Dry-Land Maze.

Neumeister KL, Riepe MW.

Int J Alzheimers Dis. 2012;2012:673584. doi: 10.1155/2012/673584. Epub 2012 Sep 29.

10.

[Dementia guidelines: what should come to general practice--an interdisciplinary consensus of physicians in private practice].

Riepe MW, Fellgiebel A; DEGAM, DGN, DGPPN.

Dtsch Med Wochenschr. 2012 Jul;137(30):1499-504. doi: 10.1055/s-0032-1305171. Epub 2012 Aug 6. German.

PMID:
22869507
11.

Synergistic effects of antidementia drugs on spatial learning and recall in the APP23 transgenic mouse model of Alzheimer's disease.

Neumeister KL, Riepe MW.

J Alzheimers Dis. 2012;30(2):245-51. doi: 10.3233/JAD-2012-111643.

PMID:
22414570
12.

Verbal episodic memory and endogenous estradiol: an association in patients with mild cognitive impairment and Alzheimer's disease.

Bittner DM, Bittner V, Riepe MW.

Curr Gerontol Geriatr Res. 2011;2011:673012. doi: 10.1155/2011/673012. Epub 2011 Dec 19.

13.

Additive scales in degenerative disease--calculation of effect sizes and clinical judgment.

Riepe MW, Wilkinson D, Förstl H, Brieden A.

BMC Med Res Methodol. 2011 Dec 16;11:169. doi: 10.1186/1471-2288-11-169.

14.

The future of Alzheimer's disease: the next 10 years.

Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C, Frölich L, Riepe MW, Dodel R, Leyhe T, Bertram L, Hoffmann W, Faltraco F; German Task Force on Alzheimer's Disease (GTF-AD).

Prog Neurobiol. 2011 Dec;95(4):718-28. doi: 10.1016/j.pneurobio.2011.11.008. Epub 2011 Nov 22. Review.

PMID:
22137045
15.

Gender-dependence of substituted judgment on quality of life in patients with dementia.

Schiffczyk C, Jonas C, Lahmeyer C, Müller F, Riepe MW.

BMC Neurol. 2011 Sep 30;11:118. doi: 10.1186/1471-2377-11-118.

16.

Staging dementia using proxy-reported activities of daily living.

Jonas C, Schiffczyk C, Lahmeyer C, Mueller F, Riepe MW.

Dement Geriatr Cogn Disord. 2011;32(2):111-7. doi: 10.1159/000331420. Epub 2011 Sep 23.

PMID:
21952470
17.

Amyloid beta 1-42 in cerebrospinal fluid is associated with cognitive plasticity.

Uttner I, Schurig N, von Arnim CA, Lange-Asschenfeldt C, Brettschneider J, Riepe MW, Tumani H.

Psychiatry Res. 2011 Nov 30;190(1):132-6. doi: 10.1016/j.psychres.2011.04.017. Epub 2011 May 26.

PMID:
21620485
18.

Measuring therapeutic efficacy in patients with Alzheimer's disease: role of instruments.

Riepe MW, Janetzky W, Lemming OM.

Dement Geriatr Cogn Disord. 2011;31(3):233-8. doi: 10.1159/000326214. Epub 2011 Apr 7.

PMID:
21474932
19.

Genetic variants in PSEN2 and correlation to CSF β-amyloid42 levels in AD.

Lebedeva E, Stingl JC, Thal DR, Ghebremedhin E, Strauss J, Özer E, Bertram L, von Einem B, Tumani H, Otto M, Riepe MW, Högel J, Ludolph AC, von Arnim CA.

Neurobiol Aging. 2012 Jan;33(1):201.e9-18. doi: 10.1016/j.neurobiolaging.2010.07.017. Epub 2010 Sep 18.

PMID:
20850903
20.

Tau-proteins as gender-specific state markers in amnestic mild cognitive impairment.

Riepe MW, Karl J, Tumani H, von Arnim CA.

Dement Geriatr Cogn Disord. 2010;30(2):93-100. doi: 10.1159/000318738. Epub 2010 Aug 18.

PMID:
20720423
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk